Nintendo's highly-anticipated successor to the Nintendo Switch, the Nintendo Switch 2, is reportedly set for a three-phase launch plan in 2025. According to Insider Gaming, the gaming console will ...

The 12V-60V three-phase GaN inverter design offers efficiency, precise current sensing, and sensorless control for robotics and motor drives. TIDA-010936 – 48V/16A small form factor three-phase GaN ...

The Bangladesh Economic Zones Authority (Beza) is developing a comprehensive three-phase implementation plan to develop economic zones across the country, ensuring balanced industrialisation ...

Three phase 3 trials of combinations including datopotamab deruxtecan for the treatment of non–small cell lung cancer are beginning. The first patients have been dosed in 3 phase 3 trials evaluating ...

Abstract: Unbalance in a three-phase system is created due to single-phase loads and distributed single-phase renewable energy sources connected to the same system. This unbalance can be compensated ...

Sigenergy has excitedly announced that its 3-phase SigenStor range is now Clean Energy Council (CEC) listed. This certification guarantees that the range meets Australia’s highest standards for ...

The decommissioning of units 1-3 is being carried out separately from that of the destroyed unit 4, which is expected to take many years longer to complete. The move into the decommissioning phase for ...

If you’re building, renovating or planning to install a solar battery, your builder or installer might ask whether you’ve considered upgrading from single-phase to three-phase power. This upgrade ...

Ocuphire Pharma announced it has dosed the first patient in its VEGA-3, phase 3 clinical trial (NCT06542497) of phentolamine ophthalmic solution 0.75% for the treatment of presbyopia. The company ...

Even before this morning’s patchy phase 3 results, Sanofi had been acclimatizing investors to a focus on reducing the progression of disability rather than preventing relapses—which has been ...

The phase 3 INVINCIBLE-3 study (NCT06263231) evaluating INT230-6 as monotherapy for the treatment of patients with metastatic sarcoma has dosed its first US patient. 1 INT230-6 is the lead proprietary ...